United Therapeutics Corp. (UTHR)
490.83
-12.86
(-2.55%)
USD |
NASDAQ |
Jan 08, 16:00
490.00
-0.83
(-0.17%)
After-Hours: 20:00
United Therapeutics Research and Development Expense (Quarterly): 127.50M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 68.85M |
| Gilead Sciences, Inc. | 1.334B |
| Johnson & Johnson | 3.693B |
| Catalyst Pharmaceuticals, Inc. | 2.657M |
| Plus Therapeutics, Inc. | 2.436M |